Vivos Therapeutics, Inc. Inventory Write-down
Vivos Therapeutics, Inc. (VVOS) reported Inventory Write-down of $151.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2023-11-14
- Vivos Therapeutics, Inc. inventory write-down for the quarter ending 2023-09-30 was $151.00K.
| Period end | Inventory Write-down 3 month | Inventory Write-down 9 month |
|---|---|---|
| 2023-09-30 | $151.00K 10-Q · filed 2023-11-14 | $151.00K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |